Journal
LEUKEMIA
Volume 21, Issue 8, Pages 1679-1690Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.leu.2404778
Keywords
AML; MN1; inv(16); CBF beta-SMMHC
Categories
Funding
- Intramural NIH HHS Funding Source: Medline
- NCI NIH HHS [CA72999, CA021765] Funding Source: Medline
Ask authors/readers for more resources
The gene encoding the transcriptional co-activator MN1 is the target of the reciprocal chromosome translocation (12;22) (p13;q12) in some patients with acute myeloid leukemia (AML). In addition, expression array analysis showed that MN1 was overexpressed in AML specified by inv(16), in some AML overexpressing ecotropic viral integration 1 site (EVI1) and in some AML without karyotypic abnormalities. Here we describe that mice receiving transplants of bone marrow (BM) overexpressing MN1 rapidly developed myeloproliferative disease (MPD). This BM also generated myeloid cell lines in culture. By mimicking the situation in human inv(16) AML, forced coexpression of MN1 and Cbf beta-SMMHC rapidly caused AML in mice. These findings identify MN1 as a highly effective hematopoietic oncogene and suggest that MN1 overexpression is an important cooperative event in human inv(16) AML.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available